[go: up one dir, main page]

NO20013337L - New treatment - Google Patents

New treatment

Info

Publication number
NO20013337L
NO20013337L NO20013337A NO20013337A NO20013337L NO 20013337 L NO20013337 L NO 20013337L NO 20013337 A NO20013337 A NO 20013337A NO 20013337 A NO20013337 A NO 20013337A NO 20013337 L NO20013337 L NO 20013337L
Authority
NO
Norway
Prior art keywords
new treatment
treatment
new
Prior art date
Application number
NO20013337A
Other languages
Norwegian (no)
Other versions
NO20013337D0 (en
Inventor
Gillian Frances Atkinson
Ronald James Boon
Pierre G Vandepapeliere
Martine Anne Cecil Wettendorff
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of NO20013337D0 publication Critical patent/NO20013337D0/en
Publication of NO20013337L publication Critical patent/NO20013337L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • A61K39/292Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20013337A 1999-01-12 2001-07-05 New treatment NO20013337L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9900630 1999-01-12
PCT/EP1999/010295 WO2000041463A2 (en) 1999-01-12 1999-12-21 Combination of hepatitis b vaccine with antiviral agents

Publications (2)

Publication Number Publication Date
NO20013337D0 NO20013337D0 (en) 2001-07-05
NO20013337L true NO20013337L (en) 2001-08-17

Family

ID=10845878

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013337A NO20013337L (en) 1999-01-12 2001-07-05 New treatment

Country Status (19)

Country Link
EP (1) EP1140163A2 (en)
JP (1) JP2002534438A (en)
KR (1) KR20010090011A (en)
CN (1) CN1391482A (en)
AR (1) AR022250A1 (en)
AU (1) AU760574B2 (en)
BR (1) BR9916893A (en)
CA (1) CA2359110A1 (en)
CO (1) CO5241355A1 (en)
CZ (1) CZ20012544A3 (en)
HK (1) HK1041434A1 (en)
HU (1) HUP0105070A2 (en)
IL (1) IL144186A0 (en)
NO (1) NO20013337L (en)
NZ (1) NZ512890A (en)
PL (1) PL349347A1 (en)
TR (1) TR200102024T2 (en)
WO (1) WO2000041463A2 (en)
ZA (1) ZA200105690B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU761899B2 (en) 1998-05-22 2003-06-12 Ottawa Health Research Institute Methods and products for inducing mucosal immunity
BRPI9912663B8 (en) 1998-07-31 2021-07-06 Int Inst Cancer Immunology Inc vaccine against cancer and polypeptide.
ES2298353T3 (en) 2001-03-22 2008-05-16 International Institute Of Cancer Immunology, Inc. MODIFIED WT1 PEPTIDE.
JPWO2003028758A1 (en) * 2001-09-28 2005-01-13 治夫 杉山 Method for inducing antigen-specific T cells
EP1447091A4 (en) 2001-09-28 2008-02-13 Institute Of Can International Novel method of inducing antigen-specific t cells
MY131488A (en) * 2002-04-08 2007-08-30 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
MXPA05004588A (en) 2002-10-29 2005-12-14 Coley Pharmaceutical Group Ltd Use of cpg oligonucleotides in the treatment of hepatitis c virus infection.
EP1578954A4 (en) 2002-12-11 2010-08-11 Coley Pharm Group Inc 5' cpg nucleic acids and methods of use
CN100443117C (en) * 2003-05-13 2008-12-17 深圳康泰生物制品股份有限公司 Hepatitis B treating vaccine prepn and its prepn process and use
US8541167B2 (en) 2004-06-03 2013-09-24 Saint Louis University Methods and compositions for vaccination
AR065504A1 (en) * 2007-02-28 2009-06-10 Ct Ingenieria Genetica Biotech COMBINED THERAPY FOR THE TREATMENT OF CHRONIC HEPATITIS B. USE.
EP3903815A4 (en) * 2018-12-24 2022-09-28 Grand Theravac Life Science (Nanjing) Co., Ltd. Pharmaceutical preparation for treating hepatitis b, preparation method therefor and use thereof
US20240207395A1 (en) * 2021-04-07 2024-06-27 Denka Company Limited Adjuvant activity enhancer and adjuvant composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0414374T3 (en) * 1989-07-25 1998-03-09 Smithkline Beecham Biolog New antigens and methods for their preparation
HUP0101047A3 (en) * 1998-03-09 2004-10-28 Smithkline Beecham Biolog Combined vaccine compositions

Also Published As

Publication number Publication date
AU760574B2 (en) 2003-05-15
BR9916893A (en) 2001-11-20
EP1140163A2 (en) 2001-10-10
AU2100900A (en) 2000-08-01
CA2359110A1 (en) 2000-07-20
KR20010090011A (en) 2001-10-17
HK1041434A1 (en) 2002-07-12
JP2002534438A (en) 2002-10-15
NO20013337D0 (en) 2001-07-05
WO2000041463A2 (en) 2000-07-20
CZ20012544A3 (en) 2002-01-16
TR200102024T2 (en) 2001-12-21
PL349347A1 (en) 2002-07-15
AR022250A1 (en) 2002-09-04
CN1391482A (en) 2003-01-15
ZA200105690B (en) 2002-09-25
NZ512890A (en) 2003-09-26
WO2000041463A3 (en) 2000-11-09
IL144186A0 (en) 2002-05-23
HUP0105070A2 (en) 2002-04-29
CO5241355A1 (en) 2003-01-31

Similar Documents

Publication Publication Date Title
NO20001870D0 (en) New procedure for treatment
DE69924365D1 (en) MASSAGER
DK1637127T3 (en) THERAPEUTIC MICROSUM
ID26056A (en) DIAPON ONCE USE
NO2010019I2 (en) 6-per-deoxy-6-per- (2-karboksetyl) thio-y-cyclodextrin
ID26389A (en) DIAPON ONCE USE
NO20014490D0 (en) Medical mixtures
NO20032122D0 (en) Improved treatment
NO20005179D0 (en) Drug treatment
DE60023454D1 (en) LAGENMATERIALEN TENSID-MODIFIED CHELATBILDERN TREATED
DE60017816D1 (en) Pacemaker
ATE269391T1 (en) LAUNDRY TREATMENT
ID24782A (en) DIAPON ONCE USE
ID25571A (en) DIAPON ONCE USE
NO20013337L (en) New treatment
DE60016600D1 (en) PACEMAKER
DE59911113D1 (en) PACEMAKER
DE69916133D1 (en) ELECTRO-NEURO-ADAPTIVE STIMULATOR
DE60023003D1 (en) HAIR TREATMENT AGENT
DE60013608D1 (en) PACEMAKER
ATE290060T1 (en) LAUNDRY TREATMENT
DE60016452D1 (en) PACEMAKER
NO20012301D0 (en) New procedure for treatment
ATA203199A (en) PROCEDURE
DK1043026T3 (en) melanoma treatment

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application